Dr Reddy's Labs Q2 Results: Healthcare major Dr Reddy's on Tuesday reported 15% drop in its consolidated net profit at Rs 1255 crore in the second quarter. It was Rs 1480 crore in the year-ago quarter ...

It seems to have pushed the pause button on its expansion plans. In Andhra Pradesh, it made a smart move to junk Jagan Mohan Reddy and join hands with Chandrababu Naidu and Pawan Kalyan. Results aside ...

Among them, Natural Star Nani and his wife, Anjana Yelavarthy, attended the ceremony to bless the happy couple on their special day. A video shared by the Nani Fans Association on Instagram ...

Ex-Andhra Pradesh Chief Minister Jagan Reddy has been accused of illegally acquiring 41.12 per cent of shares in Kakinada Seaport and 48.74 per cent in Kakinada Special Export Zone, for Rs 500 cr ...

GO-47, issued on October 21, 2023, by the previous government of Jagan Mohan Reddy, had led to the appointment of several individuals to the Waqf Board, including prominent figures such as ...

Addressing a press conference on Thursday, Mr Reddy said the Solar Energy Corporation of India (SECI), which is a central government-run public sector unit (PSU) made an offer for power to several ...

Generic drugmaker Dr. Reddy’s Laboratories has launched in India immuno-oncology drug Toripalimab for those diagnosed with nasopharyngeal carcinoma (NPC). The launch, under the Zytorvi brand ...

Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India. Toripalimab, a PD-1 inhibitor, provides a new treatment option for this rare ...

Dr. Reddy’s announced the launch of Toripalimab in India on Thursday, for patients diagnosed with nasopharyngeal carcinoma (NPC), a rare form of head and neck cancer. Toripalimab, a New Biological ...

Dr Reddy’s Laboratories on November 28 launched India's first immuno-oncology drug, Toripalimab, to treat a rare form of cancer. The drug is approved for the treatment of nasopharyngeal ...

Dr. Reddy's Laboratories Ltd., along with its subsidiaries, announced the launch of Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma ...

New Delhi, Nov 28 (PTI) Dr Reddy's Laboratories on Thursday said it has launched Toripalimab, a drug for the treatment of recurrent or metastatic nasopharyngeal carcinoma in India. Nasopharyngeal ...